Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ Ip=QtNW3
\
EG$-D@o\I
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© g1"ZpD
un -h%-e|
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© u a_w5o7
b7I0R;Zj
1.Co-stimulators (or co-stimulating molecules) |9IOZ>H9
3oH/34jj
2.NK-kB X;GU#8W
alHA&YC{K
3.Immunoglobulin superfamily ty
rP[y
/V/NL#(R
4.antigen-presenting cell (APC) ~LV]cX2J(
Q1x&Zm1v
5.death domain <bSPKTKL
'ROz| iJ
6.CCR and CXCR REK):(i7P
% X %zK1
7.Lectin (or mitogen) =RRv&
"2r
U.P1KRY|=
8.Clusters of differentiation, CD) #G F.M,O/h
k_wcol,W
9.B7 family ZCc2
3UwI
F!)[H["_
10.Cytotoxic T lymphocyte, CTL)
J9*;Bqzim
NQ 6oyg@&
11.IL-15 and IL-15 receptor (IL-15R) :}Yk0*
5 D^#6h 4
12.MHC restriction Z.Z;p/4F
'F.
P93
13.Affinity-chromatography !8[A;+o3P
O)VcW/
14.Cyctosprin A, CsA K&NH?
Er~KX3vF
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 2v4K3O60G
!s1<)%Jt
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© q/I( e
sa o &
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 2 >O [Y1
]j/=
x2p
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ L k
nK
t}h(j|
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ Q2m[XcnX
~//9Nz~;3
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© N^[
F+y
:K2
X~Ty
ÃâÒßѧרҵ£º
Ka(B&.
P`Ku
.
ONQ
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ !vu
-`u~86
Oz-/0;1n
Ïû»¯ÄÚ¿Æ£º
8el6z2
>KrI}>!9r
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 1K@ieVc
e7xv~C>g
ѪҺ²¡Ñ§×¨Òµ£º /fT"WaTEK
|Ol29C$@|
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿